New registry aims to uncover how COVID-19 drugs affect pregnant women
NCT ID NCT05013632
First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 35 times
Summary
This registry is enrolling 2000 pregnant women who received COVID-19 treatments like antiviral drugs or monoclonal antibodies. Researchers will track pregnancy outcomes, baby health, and development up to 12 months after birth. The goal is to better understand the safety of these medications during pregnancy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Pregistry
RECRUITINGLos Angeles, California, 90045, United States
Contact
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
antiviral drugs (remdesivir, molnupiravir) and monoclonal antibodies (casirivimab/imdevimab, sotrovimab)
What this could lead to
If successful, this registry could provide crucial safety data on COVID-19 treatments during pregnancy, helping doctors make informed decisions.
What could go wrong
This is an observational registry, not a controlled trial, so it cannot prove cause and effect. Results may take years and could be inconclusive.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.